John B. Harlow Jr.
Chief Commercial Officer, Esperion Therapeutics.
Companies
- Esperion TherapeuticsChief Commercial Officer Nov 17, 2025 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Esperion Therapeutics ESPR0 shares2Jul 13, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 13, 2026Returned to company 424,536 shares of Esperion Therapeutics2
- Dec 4, 2025Granted 424,536 shares of Esperion Therapeutics3
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Dec 8, 2025